Vindesine
Vindesine is a chemotherapy medication used in the treatment of various types of cancer. It belongs to the class of drugs known as vinca alkaloids, which are derived from the periwinkle plant Catharanthus roseus. Vindesine works by inhibiting the growth of cancer cells by interfering with the formation of microtubules, which are essential for cell division.
Medical Uses[edit]
Vindesine is primarily used in the treatment of:
- Acute lymphoblastic leukemia (ALL)
- Non-Hodgkin lymphoma
- Melanoma
- Lung cancer, particularly non-small cell lung cancer (NSCLC)
- Breast cancer
Mechanism of Action[edit]
Vindesine exerts its anti-cancer effects by binding to tubulin, a protein that is a key component of microtubules. By binding to tubulin, vindesine prevents the polymerization of microtubules, which is essential for mitosis (cell division). This disruption of microtubule formation leads to cell cycle arrest and ultimately, cell death.
Side Effects[edit]
Common side effects of vindesine include:
- Myelosuppression, leading to decreased levels of white blood cells, red blood cells, and platelets
- Peripheral neuropathy
- Nausea and vomiting
- Alopecia (hair loss)
- Constipation
Administration[edit]
Vindesine is administered intravenously, typically in a hospital or clinical setting. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and other factors.
History[edit]
Vindesine was first synthesized in the 1970s as a semi-synthetic derivative of vinblastine, another vinca alkaloid. It was developed to improve the therapeutic index and reduce the side effects associated with vinblastine.
See Also[edit]
References[edit]
External Links[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
